Latest Hydromorphone Stories
SOMERSET, N.J., Oct. 13 /PRNewswire/ -- Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)( )(fentanyl buccal soluble film) in the U.S.
A Swedish researcher says drugs that may cause dose dumping, releasing medication in an unsafe manner in those who have drunk alcohol, need to be tested. Hans Lennernas, a professor in Biopharmaceutics at Uppsala University in Sweden, says some controlled release pills and capsules are susceptible to dose dumping. Lennernas says a formulation of the pain medication hydromorphone is one example of dose dumping.
Controlled release pills and capsules that show a tendency in the standard laboratory test toward "dose dumping" â€” releasing their medicine in a faster and potentially unsafe manner in patients who have consumed alcohol â€” should be withheld from the market until proven safe with testing in people.
BRISTOL, Tenn., Aug. 13 /PRNewswire-FirstCall/ -- King Pharmaceuticals((R)), Inc. (NYSE: KG) today announced that the U.S.
CONSHOHOCKEN, PA and VANCOUVER, BC, June 17 /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that its subsidiary Neuromed Development Inc., has sold the U.S.
CUPERTINO, Calif., June 16 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Joseph Stauffer has joined DURECT as Chief Medical Officer and Executive Vice President, Corporate Strategy. (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) "Dr.
CONSHOHOCKEN, PA and VANCOUVER, BC, June 11 /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that it has received notification that Merck & Co., Inc.
A coroner in Las Vegas has ruled impressionist Danny Gans died accidentally of heart failure brought on by a toxic level of the pain killer hydromorphone. Clark County Coroner Mike Murphy would not characterize the May 1 death of the 52-year-old performer as a drug overdose, The New York Times reported Thursday.
- Oxycodone Successfully Delivered into the Bloodstream - Data Demonstrates Sustained Release and Increased Blood Levels of Oxycodone MELBOURNE, Australia, May 29 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful completion of preclinical studies related to its patented TPM/oxycodone transdermal patch system.
BETHESDA, Md., May 26 /PRNewswire/ -- On May 27 and 28, 2009, the Food and Drug Administration (FDA) will hear testimony about the FDA-guided effort to develop a classwide Risk Evaluation and Mitigation Strategy (REMS) for all controlled-release opioids from more than 70 patients, scientists, public health professionals, and representatives of pharmacist groups, prescriber groups, and pharmaceutical companies.
- The governor of a province or people.